CN104689218A - Traditional Chinese medicine composition for treating fatty liver - Google Patents

Traditional Chinese medicine composition for treating fatty liver Download PDF

Info

Publication number
CN104689218A
CN104689218A CN201510144711.0A CN201510144711A CN104689218A CN 104689218 A CN104689218 A CN 104689218A CN 201510144711 A CN201510144711 A CN 201510144711A CN 104689218 A CN104689218 A CN 104689218A
Authority
CN
China
Prior art keywords
parts
chinese medicine
medicine composition
fatty liver
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510144711.0A
Other languages
Chinese (zh)
Inventor
周冠旻
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510144711.0A priority Critical patent/CN104689218A/en
Publication of CN104689218A publication Critical patent/CN104689218A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a traditional Chinese medicine composition for treating a fatty liver. The traditional Chinese medicine composition comprises, by weight, 15-25 parts of poria cocos, 5-15 parts of fructus amomi, 5-15 parts of atractylodes macrocephala koidz, 5-15 parts of radix codonopsis, 5-15 parts of wrinkled gianthyssop herb, 5-15 parts of angelica sinensis, 5-15 parts of lycium barks, 5-15 parts of pepperweed seeds, 3-7 parts of semen cassiae torae and 3-7 parts of cortex magnoliae officinalis. The poria cocos having the effects of dissipating dampness for diuresis, strengthening the spleen and stomach, tranquilizing mind by nourishing the heart and the like interacts with the fructus amomi, the atractylodes macrocephala koidz, the radix codonopsis, the wrinkled gianthyssop herb, the angelica sinensis, the lycium barks, the pepperweed seeds, the semen cassiae torae and the cortex magnoliae officinalis, so that the fatty liver is effectively cured, the traditional Chinese medicine composition has the advantages of taking effect quickly, short in treatment source, remarkable in effect and the like. The raw medicinal materials of the traditional Chinese medicine composition are natural plants and are wide in resource and free of side effects, and the traditional Chinese medicine composition reasonable in formula, low in cost, and particularly suitable for treating the fatty liver.

Description

A kind of Chinese medicine composition for the treatment of fatty liver
Technical field
The present invention relates to a kind of pharmaceutical composition, be specifically related to a kind of Chinese medicine composition for the treatment of fatty liver.
Background technology
Fatty liver, refers to the pathological changes due to overheap fatty in the hepatocyte that a variety of causes causes, and is one of comprehensive disease of all kinds of hepatitis.Pathogenesis of fatty liver mechanism is not yet clear and definite so far, modern medicine is thought may be relevant with many factors, as abnormalities of sugar/lipid metabolism, hormonal readiness change, E&H factor, lipid peroxidation damage, immunoreation, anoxia and hepatic circulatory disturbance etc. play a part certain in its pathogenic process.In recent years, along with growth in the living standard, by the impact of the many factors such as living habit, dietary structure, China's fatty liver clinical onset rate becomes ascendant trend year by year.Obesity, medicine and drug intoxication, diabetes, gestation, hepatitis virus or other pathogenic infection etc. all can cause the generation of fatty liver, its clinical manifestation is directly proportional to liver fatty infiltration degree, although fatty liver is often considered to benign lesion, but great mass of data shows, regardless of the origin cause of formation, all there is partial fat hepatopath to develop into hepatic fibrosis, even liver cirrhosis, can think that fatty liver is the cercinoma prophase pathologic change of hepatic fibrosis and liver cirrhosis.The health of the positive serious threat compatriots of fatty liver disease, becomes the second largest hepatopathy being only second to viral hepatitis, has been acknowledged as the common cause of disguised liver cirrhosis.
Fatty liver belongs to reversibility disease, and early diagnosis also treatment in time often can recover normal.At present, the treatment of doctor trained in Western medicine mainly with blood fat reducing, protect the liver, fall enzyme for main doctor then, but treatment time is long, less effective, and life-time service has untoward reaction; Chinese traditional treatment fatty liver reduces phlegm with depressed liver-energy dispersing and QI regulating, dissipating phlegm and removing blood stasis, soothing liver and strengthening spleen, damp eliminating, nourishing the kidney and liver, blood circulation promoting and blood stasis dispelling, removing heat-phlegm, benefiting QI for activating blood circulation, dispersing swelling and dissipating binds etc. for principle, have certain curative effect, have no side effect.Sell treatment fatty liver medicament in the market various, but the medicine that really therapeutic effect is good is also few.
Summary of the invention
For the deficiencies in the prior art, the object of this invention is to provide a kind of short treating period, Be very effective, the Chinese medicine composition for the treatment of fatty liver that has no side effect.
In order to achieve the above object, the technical scheme that the present invention takes is:
Treat a Chinese medicine composition for fatty liver, its component is by weight: 15 ~ 25 parts, Poria, Fructus Amomi 5 ~ 15 parts, the Rhizoma Atractylodis Macrocephalae 5 ~ 15 parts, Radix Codonopsis 5 ~ 15 parts, Herba Pogostemonis 5 ~ 15 parts, Radix Angelicae Sinensis 5 ~ 15 parts, Cortex Lycii 5 ~ 15 parts, Semen Lepidii (Semen Descurainiae) 5 ~ 15 parts, Semen Cassiae 3 ~ 7 parts, Cortex Magnoliae Officinalis 3 ~ 7 parts.
As preferred component, its component is by weight: 17 ~ 23 parts, Poria, Fructus Amomi 7 ~ 13 parts, the Rhizoma Atractylodis Macrocephalae 7 ~ 13 parts, Radix Codonopsis 7 ~ 13 parts, Herba Pogostemonis 7 ~ 13 parts, Radix Angelicae Sinensis 7 ~ 13 parts, Cortex Lycii 7 ~ 13 parts, Semen Lepidii (Semen Descurainiae) 7 ~ 13 parts, Semen Cassiae 4 ~ 6 parts, Cortex Magnoliae Officinalis 4 ~ 6 parts.
As preferred component, its component is by weight: 19 ~ 21 parts, Poria, Fructus Amomi 9 ~ 11 parts, the Rhizoma Atractylodis Macrocephalae 9 ~ 11 parts, Radix Codonopsis 9 ~ 11 parts, Herba Pogostemonis 9 ~ 11 parts, Radix Angelicae Sinensis 9 ~ 11 parts, Cortex Lycii 9 ~ 11 parts, Semen Lepidii (Semen Descurainiae) 9 ~ 11 parts, Semen Cassiae 5 ~ 6 parts, Cortex Magnoliae Officinalis 5 ~ 6 parts.
As more excellent composition, its component is by weight: 20 parts, Poria, Fructus Amomi 10 parts, the Rhizoma Atractylodis Macrocephalae 10 parts, Radix Codonopsis 10 parts, Herba Pogostemonis 10 parts, Radix Angelicae Sinensis 10 parts, Cortex Lycii 10 parts, Semen Lepidii (Semen Descurainiae) 10 parts, Semen Cassiae 5 parts, Cortex Magnoliae Officinalis 5 parts.
The instructions of taking of medicine of the present invention: cleaned by crude drug and be ground into powder, add and be decocted in water for oral dose, also can make the oral medicines such as tablet, granule, oral liquid, capsule by powder sterilization further.
Crude drug of the present invention has following pharmacology:
Poria, the property of medicine is sweet, light, flat, has effect of eliminating dampness and diuresis, invigorating the spleen and regulating the stomach, mind tranquilizing and the heart calming; Fructus Amomi, property of medicine acrid in the mouth, warm in nature, there is removing dampness appetizing, promoting the circulation of QI to alleviate the stagnation in middle-JIAO, warming spleen and stopping diarrha effect; The Rhizoma Atractylodis Macrocephalae, property of medicine bitter in the mouth, sweet, warm in nature, there is effect that invigorating the spleen and benefiting QI, dampness diuretic, hidroschesis are antiabortive; Radix Codonopsis, property of medicine sweet in the mouth, property are flat, have effect of strengthening the spleen and tonifying the lung, supplementing QI for promoting the production of body fluid; Herba Pogostemonis, property of medicine acrid in the mouth, slightly warm in nature, have effect of dispelling summer-heat from superficies of the body, removing dampness to restore normal function of the stomach; Radix Angelicae Sinensis, property of medicine sweet in the mouth, pungent, bitter, warm in nature, having enriches blood invigorates blood circulation, menstruction regulating and pain relieving, moisturize effect of laxation; Cortex Lycii, property of medicine sweet in the mouth, cold in nature, there is effect of clearind deficient heat, purte the white, removing heat from blood; Semen Lepidii (Semen Descurainiae), property of medicine acrid in the mouth, hardship, cool in nature, there is rich heat clearly mutually, removing toxic substances, relieving cough and resolving phlegm, the effect of relievining asthma; Semen Cassiae, the salty hardship of the property of medicine, Pingliang, nontoxic, there is effect of expelling wind and clearing away heat, detoxification and promoting urination.
Beneficial effect of the present invention: adopt and there are wet diuretic, invigorating the spleen and regulating the stomach, the Poria of effect of mind tranquilizing and the heart calming and Fructus Amomi, the Rhizoma Atractylodis Macrocephalae, Radix Codonopsis, Herba Pogostemonis, Radix Angelicae Sinensis, Cortex Lycii, Semen Lepidii (Semen Descurainiae), Semen Cassiae, these Chinese medicinal herbses of Cortex Magnoliae Officinalis interact, effective treatment fatty liver, has rapid-action, the feature such as short treating period, Be very effective; Crude drug of the present invention is all natural plants, and source is wide, has no side effect, and formula is reasonable and cost is low.
Be described further below in conjunction with the beneficial effect of clinical trial to this medicine:
Patient data: patient 40 example, man 25 example, female 15 example; At 25 ~ 60 years old age, clarify a diagnosis as fatty liver.
Symptoms: fatigue and asthenia, facial lower jaw part is fat swollen, sticky in VI, and VI is bitter, the normal ulcer in VI chamber, excessive phlegm, feel sick indigestion and loss of appetite, abdominal distention feeling of fullness, has a dizzy spell, uncomfortable in chest, often heaves a deep sigh, two side of body dull pain or twinges, large loose stool and not well, yellow fur is thick satiny, while there is indentation, the symptoms such as soft pulse is sliding.
Efficacy determination: recovery from illness, fatigue and asthenia, the edema of the face, the common classical symptom such as uncomfortable in chest and sign disappear, and more than 3 months are without exception; Effective: fatigue and asthenia during outbreak, the edema of the face, the symptoms such as common classical symptom such as uncomfortable in chest and sign obviously alleviate than before.Invalid: treat more than 3 courses for the treatment of, the state of an illness is substantially unchanged or increase the weight of.
Efficacy result: recovery from illness 27 example, accounts for 67.5%; Effective 12 examples, account for 30%; Invalid 1 example, accounts for 2.5%; Total effective rate is 97.5%.
Model case:
Example one, Mr. Li, man, 38 years old, sugariness non-staple foodstuff is eaten in frequent happiness, drinking beer, in the recent period because of discomfort of going on business, and patient's obesity, slightly activity is just pant, and loses heart weak, and extremity asthenia is drowsy, bitter and tasteless in mouthful, anorexia, tripe abdomen feeling of fullness, middle hypogastric region falling inflation is uncomfortable, abdominal part is by being as good as block, and liver can touch, and spleen is little, lymph node end lay one's hand on and, blood fat is high, and B ultrasonic shows: fatty liver, white and greasy fur and thick, soft pulse.Take the present invention.Take this Chinese medicine, potion on the one, every day three times, after serveing on l5 days, all cards all remove, dining postabdomen slightly flatulence, extremity are slightly aching and limp, and B ultrasonic further consultation is the same, and blood fat is normal, after continuing to take first quarter moon, follow up a case by regular visits to all good, follow up a case by regular visits to again once after March, figure is slightly thin, and end sees that other is abnormal.
Example two, Mrs Wang, female, 52 years old, patient's ferritic was fat, because for the treatment of of having a rest of being in after right ankle joint trauma surgery, original chronic gastritis, brings out gastropathy because taking treatment wound medicine, add that activity is few, disposition is anxious, and disease sees that gastral cavity abdominal distention is large as drum, right flank dull pain, vows that gas is many, bitter and anorexia in mouth, poor memory, insomnia, being irritable and getting angry easily, stool viscous is not well, and enlarged abdomen is soft without enclosed mass by it, and lymph node end is touched.B ultrasonic shows: fatty liver, sclera is slight xanthochromia, and thick fur is greasy, and deep and stringy pulse is strong.Card belongs to stagnation of QI due to depression of the liver.Control with dispersing the stagnated live-QI to relieve the stagnation of QI, treatment of arthritis and promoting collateral and channels.Side is with the treatment of Chai Hu Shu Gan San plus-minus.Take this Chinese medicine, potion on the one, every day three times, after serveing on 20 days, all cards all remove, after continuing to take first quarter moon, follow up a case by regular visits to that all are all good, and follow up a case by regular visits to again once after March, figure is slightly thin, and end sees that other is abnormal.
Detailed description of the invention
Below in conjunction with specific embodiment, the present invention is further described.
Embodiment 1
Treat a Chinese medicine composition for fatty liver, its component is by weight: 15 parts, Poria, Fructus Amomi 5 parts, the Rhizoma Atractylodis Macrocephalae 5 parts, Radix Codonopsis 5 parts, Herba Pogostemonis 15 parts, Radix Angelicae Sinensis 15 parts, Cortex Lycii 15 parts, Semen Lepidii (Semen Descurainiae) 15 parts, Semen Cassiae 3 parts, Cortex Magnoliae Officinalis 7 parts.By crude drug washing and sterilizing in proportion, add and be decocted in water for oral dose.
Embodiment 2
Treat a Chinese medicine composition for fatty liver, its component is by weight: 17 parts, Poria, Fructus Amomi 7 parts, the Rhizoma Atractylodis Macrocephalae 7 parts, Radix Codonopsis 7 parts, Herba Pogostemonis 13 parts, Radix Angelicae Sinensis 13 parts, Cortex Lycii 13 parts, Semen Lepidii (Semen Descurainiae) 13 parts, Semen Cassiae 4 parts, Cortex Magnoliae Officinalis 6 parts.By crude drug washing and sterilizing in proportion, be ground into powder and make tablet further.
Embodiment 3
Treat a Chinese medicine composition for fatty liver, its component is by weight: 20 parts, Poria, Fructus Amomi 10 parts, the Rhizoma Atractylodis Macrocephalae 10 parts, Radix Codonopsis 10 parts, Herba Pogostemonis 10 parts, Radix Angelicae Sinensis 10 parts, Cortex Lycii 10 parts, Semen Lepidii (Semen Descurainiae) 10 parts, Semen Cassiae 5 parts, Cortex Magnoliae Officinalis 5 parts.By crude drug in proportion washing and sterilizing be ground into powder and make particulate oral medicine further.
Embodiment 4
Treat a Chinese medicine composition for fatty liver, its component is by weight: 23 parts, Poria, Fructus Amomi 13 parts, the Rhizoma Atractylodis Macrocephalae 13 parts, Radix Codonopsis 13 parts, Herba Pogostemonis 7 parts, Radix Angelicae Sinensis 7 parts, Cortex Lycii 7 parts, Semen Lepidii (Semen Descurainiae) 7 parts, Semen Cassiae 6 parts, Cortex Magnoliae Officinalis 4 parts.By crude drug washing and sterilizing in proportion, be ground into powder and make oral liquid further.
Embodiment 5
Treat a Chinese medicine composition for fatty liver, its component is by weight: 25 parts, Poria, Fructus Amomi 15 parts, the Rhizoma Atractylodis Macrocephalae 15 parts, Radix Codonopsis 15 parts, Herba Pogostemonis 5 parts, Radix Angelicae Sinensis 5 parts, Cortex Lycii 5 parts, Semen Lepidii (Semen Descurainiae) 5 parts, Semen Cassiae 7 parts, Cortex Magnoliae Officinalis 3 parts.By crude drug washing and sterilizing in proportion, be ground into powder and make capsule further.
It should be pointed out that above case is only the representational example of the present invention.Obviously, technical scheme of the present invention is not limited to above-described embodiment, can also have many degeneration.

Claims (4)

1. treat the Chinese medicine composition of fatty liver for one kind, it is characterized in that, its component is by weight: 15 ~ 25 parts, Poria, Fructus Amomi 5 ~ 15 parts, the Rhizoma Atractylodis Macrocephalae 5 ~ 15 parts, Radix Codonopsis 5 ~ 15 parts, Herba Pogostemonis 5 ~ 15 parts, Radix Angelicae Sinensis 5 ~ 15 parts, Cortex Lycii 5 ~ 15 parts, Semen Lepidii (Semen Descurainiae) 5 ~ 15 parts, Semen Cassiae 3 ~ 7 parts, Cortex Magnoliae Officinalis 3 ~ 7 parts.
2. a kind of Chinese medicine composition for the treatment of fatty liver according to claim 1, it is characterized in that, its component is by weight: 17 ~ 23 parts, Poria, Fructus Amomi 7 ~ 13 parts, the Rhizoma Atractylodis Macrocephalae 7 ~ 13 parts, Radix Codonopsis 7 ~ 13 parts, Herba Pogostemonis 7 ~ 13 parts, Radix Angelicae Sinensis 7 ~ 13 parts, Cortex Lycii 7 ~ 13 parts, Semen Lepidii (Semen Descurainiae) 7 ~ 13 parts, Semen Cassiae 4 ~ 6 parts, Cortex Magnoliae Officinalis 4 ~ 6 parts.
3. a kind of Chinese medicine composition for the treatment of fatty liver according to claim 2, it is characterized in that, its component is by weight: 19 ~ 21 parts, Poria, Fructus Amomi 9 ~ 11 parts, the Rhizoma Atractylodis Macrocephalae 9 ~ 11 parts, Radix Codonopsis 9 ~ 11 parts, Herba Pogostemonis 9 ~ 11 parts, Radix Angelicae Sinensis 9 ~ 11 parts, Cortex Lycii 9 ~ 11 parts, Semen Lepidii (Semen Descurainiae) 9 ~ 11 parts, Semen Cassiae 5 ~ 6 parts, Cortex Magnoliae Officinalis 5 ~ 6 parts.
4. a kind of Chinese medicine composition for the treatment of fatty liver according to claim 3, it is characterized in that, its component is by weight: 20 parts, Poria, Fructus Amomi 10 parts, the Rhizoma Atractylodis Macrocephalae 10 parts, Radix Codonopsis 10 parts, Herba Pogostemonis 10 parts, Radix Angelicae Sinensis 10 parts, Cortex Lycii 10 parts, Semen Lepidii (Semen Descurainiae) 10 parts, Semen Cassiae 5 parts, Cortex Magnoliae Officinalis 5 parts.
CN201510144711.0A 2015-03-31 2015-03-31 Traditional Chinese medicine composition for treating fatty liver Pending CN104689218A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510144711.0A CN104689218A (en) 2015-03-31 2015-03-31 Traditional Chinese medicine composition for treating fatty liver

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510144711.0A CN104689218A (en) 2015-03-31 2015-03-31 Traditional Chinese medicine composition for treating fatty liver

Publications (1)

Publication Number Publication Date
CN104689218A true CN104689218A (en) 2015-06-10

Family

ID=53337042

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510144711.0A Pending CN104689218A (en) 2015-03-31 2015-03-31 Traditional Chinese medicine composition for treating fatty liver

Country Status (1)

Country Link
CN (1) CN104689218A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108853202A (en) * 2018-08-10 2018-11-23 因之彩生物科技(武汉)有限公司 A kind of pharmaceutical preparation that treating fatty liver and its application
CN109260304A (en) * 2018-10-15 2019-01-25 黑龙江八农垦大学 A kind of compound Chinese medicinal preparation for preventing nonalcoholic fatty liver
CN110621327A (en) * 2017-08-03 2019-12-27 株式会社一圆生物 Composition containing amomum villosum extract for preventing and treating fatty liver

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103394036A (en) * 2013-08-06 2013-11-20 孟钧 Traditional Chinese medicine powder for treating fatty liver
KR20130128755A (en) * 2012-05-18 2013-11-27 한국인스팜(주) Composition comprising an extract of combined crude drug for preventing and treating hangover or liver disease

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130128755A (en) * 2012-05-18 2013-11-27 한국인스팜(주) Composition comprising an extract of combined crude drug for preventing and treating hangover or liver disease
CN103394036A (en) * 2013-08-06 2013-11-20 孟钧 Traditional Chinese medicine powder for treating fatty liver

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
李柳骥: "《超简单实用的小偏方》", 31 March 2014, 中国医药科技出版社 *
李知夭等: "《为自己诊治常见病——感冒、失眠、高血压、高血脂症、糖尿病》", 30 June 2012, 华东师范大学出版社 *
漆云良等: "中西结合治疗脂肪肝临床观察", 《实用临床医学》 *
谢英彪: "《一本书读懂肝病》", 31 May 2012, 中原农民出版社 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110621327A (en) * 2017-08-03 2019-12-27 株式会社一圆生物 Composition containing amomum villosum extract for preventing and treating fatty liver
EP3616705A4 (en) * 2017-08-03 2020-04-15 Corporation Ilwonbio Composition for improving prevention and treatment of fatty liver containingamomum vilosum
JP2020518664A (en) * 2017-08-03 2020-06-25 コーポレーション イルウォンバイオCorporation Ilwonbio Composition for preventing, treating or improving fatty liver containing Yangchun sand extract
CN108853202A (en) * 2018-08-10 2018-11-23 因之彩生物科技(武汉)有限公司 A kind of pharmaceutical preparation that treating fatty liver and its application
CN109260304A (en) * 2018-10-15 2019-01-25 黑龙江八农垦大学 A kind of compound Chinese medicinal preparation for preventing nonalcoholic fatty liver

Similar Documents

Publication Publication Date Title
CN104107387A (en) Traditional Chinese medicinal composition for treating chronic gastritis
CN104623598A (en) Traditional Chinese medicine composition for treating deficiency-cold in spleen and stomach
CN103550687B (en) A kind of Chinese medicine composition for the treatment of the hepatic and renal YIN deficiency
CN103550661B (en) A kind of Chinese medicine composition for the treatment of cold syndrome of the stomach stomachache
CN104689218A (en) Traditional Chinese medicine composition for treating fatty liver
CN102430105B (en) Traditional Chinese medicine composite for treating chronic gastritis
CN104857267A (en) Traditional Chinese medicine for weight loss
CN103735788A (en) Traditional Chinese medicine composition for treating edema
CN101095780A (en) Chinese traditional medicine preparations for treating diabetes fatty liver
CN102949685A (en) Traditional Chinese medicine composition for treating chronic gastritis
CN103463588B (en) A kind of Chinese medicine composition for the treatment of sinking of QI of middle-JIAO
CN104857188A (en) Traditional Chinese medicine composite for treating edema
CN103735907A (en) Traditional Chinese medicine for treating facial neuritis
CN103251889A (en) Traditional Chinese medicine composition for treating agalactia
CN105902872A (en) Traditional Chinese medicine composition for treating edema
CN104606395A (en) Traditional Chinese medicine prescription treating menstrual fever
CN104225315A (en) Traditional Chinese medicine composition for treating constipation
CN102872287A (en) Traditional Chinese medicine composition for treating femoral head necrosis and preparation method thereof
CN102784256B (en) Chinese medicine composition for treating arthralgia-synadrome
CN102335314B (en) Chinese medicinal composition for treating stomach diseases
CN104758888A (en) Traditional Chinese medicine composition for treating diabetes
CN105362596A (en) Traditional Chinese medicine for treating pulmonary emphysema and preparation method thereof
CN105687836A (en) Qi tonifying and yang warming paralysis eliminating soup and preparing method thereof
CN105169229A (en) Cortex acanthopanacis wine for treating arthralgia caused by rheumatoid arthritis and rheumatic arthritis and preparation method thereof
CN105561115A (en) Traditional Chinese medicinal composition for treating uremia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150610